Safety and Efficacy of Turoctocog Alfa in the Prevention and Treatment of Bleeding Episodes in Previously Treated Patients from China with Severe Hemophilia A: Results from the Guardian 7 Trial

Safety and Efficacy of Turoctocog Alfa in the Prevention and Treatment of Bleeding Episodes in Previously Treated Patients from China with Severe Hemophilia A: Results from the Guardian 7 Trial

Runhui Wu,1 Jing Sun,2 Weiqun Xu,3 Qun Hu,4 Wenqian Li,5 Jianwen Xiao,6 Feng’e Yang,7 Xiaojing Zeng,8 Yun Zeng,9 Jianfeng Zhou,4 Irina Matytsina,10 Sali Zhang,11 Michael Pluta,12 Renchi Yang13 1Hematology Oncology Center, Beijing Children’s Hospital, Capital Medical University, N...

Full description

Bibliographic Details
Main Authors: Wu R, Sun J, Xu W, Hu Q, Li W, Xiao J, Yang F, Zeng X, Zeng Y, Zhou J, Matytsina I, Zhang S, Pluta M, Yang R
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Therapeutics and Clinical Risk Management
Subjects:
hemophilia a
prophylaxis
recombinant factor viii
turoctocog alfa
china
Online Access:https://www.dovepress.com/safety-and-efficacy-of-turoctocog-alfa-in-the-prevention-and-treatment-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/safety-and-efficacy-of-turoctocog-alfa-in-the-prevention-and-treatment-peer-reviewed-article-TCRM

Similar Items